I think I go that Dan, was just surprised no one had made the out over the weekend comment!
I'd think around 6p is the new support level but as for it going up or down between now & Monday, that's a long time in the current climate. If no news I expect it to bumble along. I do however suspect we'll get news next week as it's unusually quiet on their PR front. Challenge study results or preliminary findings and you could see your double digit target quite quickly.
Lols... I sold half mine for just over 1p before close of play yesterday. Having been here for a while I know how it likes to spike. Will wait a while before I buy back in for things to settle. Still have a nice holding and in profit for now so happy for now. Long term I still have belief that this will come good but need a bit more reassurance yet for the SP to stabilise.
For those that jumped in and may not know.... There's a proactive webinar event tonight at 6pm. Think they tweeted it on their twitter the other day so try find that for details. Might be interesting to see what they have to say. And for all the naysayers about it being offered for free. Let's just call it a loss leader. Once it's adopted they'll hopefully never look back.
According to a tweet from Tom they're offering Bleepa for free to the NHS trusts at the moment. From the initial pilot results it's probably one of those things that once they get used to using they'll wonder how they coped before. On going sales and exposure could be huge.
Anything could happen. Some of the old HVO share holders will remember what happened to the SP when the Flu-v phase 2 results were published. It was mental. Having initially got in at around 18p it topped from memory around £1.40 before beginning it's downward spiral. I took my profits and more at 80p but still kept a small amount. I've been loading up since it became orph. Personally I think we're in a more sound financial position that we were back then although sadly the prevailing market conditions aren't what they were. This though, has got to be one of the best propositions on AIM at the mo. Very little downside risk compared to the upside. And, if nothing major happens between now and Monday you can still buy at lower than the last raise. No brainer really. DYOR etc.
I hope our new hires are working their socks off. NHS should be all over an app like Bleepa; Remote diagnostics of medical grade images without patient or colleague contact. Not to mention TEXRAD lung & Cadran. If they can't get something out of this mess then gawd knows what they're playing at. Come on Tom, pull something out of the bag and would you.